Literature DB >> 25348604

Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome.

Diego Oddi1, Enejda Subashi2, Silvia Middei1, Luigi Bellocchio3, Valerie Lemaire-Mayo2, Manuel Guzmán3, Wim E Crusio2, Francesca R D'Amato1, Susanna Pietropaolo2.   

Abstract

Converging lines of evidence support the use of environmental stimulation to ameliorate the symptoms of a variety of neurodevelopmental disorders. Applying these interventions at very early ages is critical to achieve a marked reduction of the pathological phenotypes. Here we evaluated the impact of early social enrichment in Fmr1-KO mice, a genetic mouse model of fragile X syndrome (FXS), a major developmental disorder and the most frequent monogenic cause of autism. Enrichment was achieved by providing male KO pups and their WT littermates with enhanced social stimulation, housing them from birth until weaning with the mother and an additional nonlactating female. At adulthood they were tested for locomotor, social, and cognitive abilities; furthermore, dendritic alterations were assessed in the hippocampus and amygdala, two brain regions known to be involved in the control of the examined behaviors and affected by spine pathology in Fmr1-KOs. Enrichment rescued the behavioral FXS-like deficits displayed in adulthood by Fmr1-KO mice, that is, hyperactivity, reduced social interactions, and cognitive deficits. Early social enrichment also eliminated the abnormalities shown by adult KO mice in the morphology of hippocampal and amygdala dendritic spines, namely an enhanced density of immature vs mature types. Importantly, enrichment did not induce neurobehavioral changes in WT mice, thus supporting specific effects on FXS-like pathology. These findings show that early environmental stimulation has profound and long-term beneficial effects on the pathological FXS phenotype, thereby encouraging the use of nonpharmacological interventions for the treatment of this and perhaps other neurodevelopmental diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25348604      PMCID: PMC4367453          DOI: 10.1038/npp.2014.291

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

1.  Is fragile X mental retardation protein involved in activity-induced plasticity of dendritic spines?

Authors:  Menahem Segal; Ute Kreher; Varda Greenberger; Katharina Braun
Journal:  Brain Res       Date:  2003-05-16       Impact factor: 3.252

Review 2.  The amygdaloid complex: anatomy and physiology.

Authors:  P Sah; E S L Faber; M Lopez De Armentia; J Power
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

3.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

4.  Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress.

Authors:  D Liu; J Diorio; B Tannenbaum; C Caldji; D Francis; A Freedman; S Sharma; D Pearson; P M Plotsky; M J Meaney
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 5.  Synaptic regulation of protein synthesis and the fragile X protein.

Authors:  W T Greenough; A Y Klintsova; S A Irwin; R Galvez; K E Bates; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

Authors:  S A Irwin; B Patel; M Idupulapati; J B Harris; R A Crisostomo; B P Larsen; F Kooy; P J Willems; P Cras; P B Kozlowski; R A Swain; I J Weiler; W T Greenough
Journal:  Am J Med Genet       Date:  2001-01-15

7.  Adult fragile X syndrome. Clinico-neuropathologic findings.

Authors:  R D Rudelli; W T Brown; K Wisniewski; E C Jenkins; M Laure-Kamionowska; F Connell; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Preweaning enrichment has no lasting effects on adult hippocampal neurogenesis in four-month-old mice.

Authors:  Z Kohl; H G Kuhn; C M Cooper-Kuhn; J Winkler; L Aigner; G Kempermann
Journal:  Genes Brain Behav       Date:  2002-01       Impact factor: 3.449

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

Review 10.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

View more
  23 in total

1.  Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome.

Authors:  Luis A Martinez; Maria Victoria Tejada-Simon
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

2.  Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.

Authors:  L A Martinez; Maria Victoria Tejada-Simon
Journal:  Mol Neurobiol       Date:  2017-07-08       Impact factor: 5.590

Review 3.  Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Authors:  Christina Gross; Anne Hoffmann; Gary J Bassell; Elizabeth M Berry-Kravis
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 4.  Treatment of the psychiatric problems associated with fragile X syndrome.

Authors:  Randi J Hagerman; Jonathan Polussa
Journal:  Curr Opin Psychiatry       Date:  2015-03       Impact factor: 4.741

Review 5.  Modeling dopamine dysfunction in autism spectrum disorder: From invertebrates to vertebrates.

Authors:  Gabriella E DiCarlo; Mark T Wallace
Journal:  Neurosci Biobehav Rev       Date:  2021-12-11       Impact factor: 8.989

6.  Influence of Gestational Chlorpyrifos Exposure on ASD-like Behaviors in an fmr1-KO Rat Model.

Authors:  Cristian Perez-Fernandez; María Matamala Montoya; Miguel Morales-Navas; Laia Guardia-Escote; María Cabré; María Teresa Colomina; Estela Giménez; Fernando Sánchez-Santed
Journal:  Mol Neurobiol       Date:  2022-07-08       Impact factor: 5.682

7.  Potential Involvement of Impaired BKCa Channel Function in Sensory Defensiveness and Some Behavioral Disturbances Induced by Unfamiliar Environment in a Mouse Model of Fragile X Syndrome.

Authors:  Maria Isabel Carreno-Munoz; Fabienne Martins; Maria Carmen Medrano; Elisabetta Aloisi; Susanna Pietropaolo; Corentin Dechaud; Enejda Subashi; Guillaume Bony; Melanie Ginger; Abdelmalik Moujahid; Andreas Frick; Xavier Leinekugel
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

Review 8.  Channelopathies in fragile X syndrome.

Authors:  Pan-Yue Deng; Vitaly A Klyachko
Journal:  Nat Rev Neurosci       Date:  2021-04-07       Impact factor: 34.870

Review 9.  Ultrasonic vocalizations in mice: relevance for ethologic and neurodevelopmental disorders studies.

Authors:  Marika Premoli; Maurizio Memo; Sara Anna Bonini
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 10.  Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome.

Authors:  Tao Yang; Huan Zhao; Changbo Lu; Xiaoyu Li; Yingli Xie; Hao Fu; Hui Xu
Journal:  Neural Plast       Date:  2016-04-28       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.